share_log

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

New AvalonSelect Genetic Network Offers Health Plans Control, Quality, and Savings in Genetic Testing

新的 AvalonSelect 基因網絡提供健康計劃、控制、質量和基因檢測方面的節約
PR Newswire ·  03/12 23:30

New testing network benefits plans, providers, and members.

新的測試網絡福利計劃、提供商和成員。

TAMPA, Fla., March 12, 2024 /PRNewswire/ -- Health plans overwhelmed by the explosive growth in genetic testing can now manage the tests that ensure quality, decrease costs, and reduce administrative burden.

佛羅里達州坦帕,2024年3月12日 /PRNewswire/ — 由於基因檢測的爆炸性增長,健康計劃現在可以管理檢測,從而確保質量、降低成本和減輕管理負擔。

AvalonSelect Genetic Network from Avalon Healthcare Solutions, the world's first lab insights company, is a carefully curated group of genetic testing labs paired with expert consultative services. A supplement to health plans' current routine testing networks, it was created specifically to address genetic testing. Health plans outsource the management of genetic testing, pricing, compliance enforcement, test quality assessment, new test evaluation, and contracting to Avalon.

全球第一家實驗室洞察公司Avalon Healthcare Solutions旗下的AvalonSelect遺傳網絡是一組精心策劃的基因檢測實驗室,提供專家諮詢服務。它是對健康計劃當前常規檢測網絡的補充,是專門爲解決基因檢測問題而創建的。健康計劃將基因檢測、定價、合規執法、測試質量評估、新測試評估和合同的管理外包給阿瓦隆。

"Genetic testing is an important precision medicine tool, but like any technology it needs to be managed correctly to provide the maximum benefit," said Avalon President Pamela Stahl. "AvalonSelect Genetic Network provides plans with a simplified approach to genetic test management while improving the quality of genetic tests provided to members."

阿瓦隆總裁帕梅拉·斯塔爾說:“基因檢測是一種重要的精準醫療工具,但與任何技術一樣,需要對其進行正確管理以提供最大的益處。”“AvalonSelect遺傳網絡爲計劃提供簡化的基因測試管理方法,同時提高了提供給成員的基因測試的質量。”

Plans and providers are simply overwhelmed by the rapid rise in the number and variety of genetic tests. More than 175,000 tests are on the market, and more than 10 new ones are added daily. The volume is just too great for plans to be able to evaluate the clinical utility and validity of each test. Similarly, providers cannot familiarize themselves with every possible test or know how to integrate their results into care decisions. Ensuring access to quality testing while controlling costs has become increasingly complex and resource intensive. Also, more states are passing biomarker legislation mandating insurers cover types of genetic testing, which will only add to the volume and spending.

基因檢測數量和種類的迅速增加簡直讓計劃和提供者不知所措。市場上有超過17.5萬次測試,每天增加10多個新測試。體積太大了,計劃無法評估每項測試的臨床效用和有效性。同樣,提供者無法熟悉所有可能的測試,也無法知道如何將其結果納入護理決策。在控制成本的同時確保獲得質量測試的機會已變得越來越複雜和資源密集。此外,越來越多的州正在通過生物標誌物立法,要求保險公司承保基因檢測的種類,這隻會增加數量和支出。

AvalonSelect Genetic Network offers plans an average savings of 10% or more on overall genetic test spending leveraging a preferred nationwide program. It is based on Avalon's extensive lab contracting experience and evidence-based new test evaluations to drive access to quality tests while simplifying the complexity and costs of genetic testing. It includes:

AvalonSelect 遺傳網絡利用首選的全國性計劃,爲計劃提供平均基因檢測總支出節省10%或更多的費用。它基於Avalon豐富的實驗室簽約經驗和基於證據的新測試評估,旨在提高獲得質量測試的機會,同時簡化基因測試的複雜性和成本。它包括:

  • Reduced or eliminated prior authorization (PA) for gold-carded lab providers
  • Simplified administration and reduced health plan burden
  • Quality enforcement through strict performance criteria
  • Credentialing support and emerging technology review service
  • An improved provider experience and consistent reimbursement expectations
  • Reduced potential for fraud, waste, and abuse
  • Collaboration with the plan's internal network team
  • 減少或取消了金卡實驗室提供商的事先授權 (PA)
  • 簡化管理,減輕健康計劃負擔
  • 通過嚴格的績效標準執行質量
  • 認證支持和新興技術審查服務
  • 改善的提供商體驗和穩定的報銷預期
  • 減少欺詐、浪費和濫用的可能性
  • 與該計劃的內部網絡團隊合作

The AvalonSelect Genetic Network is comprised of quality genetic labs that perform non-proprietary, high-volume testing covering 95% of the total genetic test menu. Labs want to join AvalonSelect because it offers reduced PA, fast-tracked reimbursement, increased volume, and assured reimbursement price, timing, and transparency.

AvalonSelect 遺傳網絡由高質量的遺傳實驗室組成,這些實驗室進行非專有的大批量測試,涵蓋基因測試總菜單的 95%。實驗室之所以想加入 AvalonSelect,是因爲它提供更低的 PA、快速的報銷、更高的數量以及有保障的報銷價格、時間和透明度。

"Genetic testing is too complex and fast-growing to be managed by the system now in place for routine testing," said Jason Bush, Executive Vice President of Product at Avalon. "It requires a solution designed to meet the specific challenges of genetic testing while ensuring a cost-effective, member-friendly lab network strategy that promotes appropriate utilization and directs members to high-quality labs."

阿瓦隆產品執行副總裁傑森·布什說:“基因檢測過於複雜且增長迅速,無法由目前用於常規測試的系統進行管理。”“它需要一種旨在應對基因檢測特定挑戰的解決方案,同時確保具有成本效益、對成員友好的實驗室網絡策略,以促進適當利用並將成員引導到高質量的實驗室。”

Genetic testing will become an even more critical part of healthcare. AvalonSelect Genetic Network offers plans a better way to harness it for their benefit and that of their members and providers.

基因檢測將成爲醫療保健中更加關鍵的部分。AvalonSelect遺傳網絡爲計劃提供了一種更好的方法來利用計劃爲他們及其成員和提供者的利益謀利。

For more information about AvalonSelect Genetic Network, click here.

有關AvalonSelect遺傳網絡的更多信息,請單擊此處。

About Avalon Healthcare Solutions
Avalon Healthcare Solutions is the world's first and only Lab Insights company, bringing together our proven Lab Benefit Management solutions, lab science expertise, digitized lab values, and proprietary analytics to help healthcare insurers proactively inform appropriate care, reduce costs, and improve clinical outcomes. Working with health plans nationwide, the company covers over 39+ million lives and delivers 9-20% outpatient lab benefit savings. Avalon is pioneering a new era of value-driven care with its Lab Insights Program that captures, digitizes, and analyzes lab results in real-time to provide actionable insights for earlier disease detection, ensuring appropriate treatment protocols, and driving down overall costs. For more information about Avalon, visit .

關於 Avalon 醫療保健解決方案
Avalon Healthcare Solutions是世界上第一家也是唯一一家Lab Insights公司,它彙集了我們久經考驗的實驗室福利管理解決方案、實驗室科學專業知識、數字化實驗室價值觀和專有分析,以幫助醫療保險公司主動爲適當的護理提供信息,降低成本並改善臨床結果。該公司與全國各地的健康計劃合作,覆蓋了超過3900萬人的生命,並節省了9-20%的門診實驗室福利。Avalon 通過其 Lab Insights 計劃開創了價值驅動型護理的新時代,該計劃實時捕獲、數字化和分析實驗室結果,爲早期疾病檢測提供切實可行的見解,確保適當的治療方案,降低總體成本。有關阿瓦隆的更多信息,請訪問。

Media Contacts:
Michele Norton MS, RN
SVP Product Marketing, Avalon Healthcare Solutions
[email protected]

媒體聯繫人:
米歇爾·諾頓 MS、RN
Avalon 醫療保健解決方案產品營銷高級副總裁
[電子郵件保護]

Janet Mordecai
Amendola Communications for Avalon Healthcare Solutions
[email protected]

珍妮特·莫迪凱
Avalon 醫療保健解決方案的 Amendola Communications
[電子郵件保護]

SOURCE Avalon Healthcare Solutions

來源 Avalon 醫療保健解決方案

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論